Oncogene, Grail CEO, Epstein, Prasad: Readout Newsletter
Wish to keep on high of the science and politics driving biotech right this moment? Enroll to get our biotech publication in ...
Wish to keep on high of the science and politics driving biotech right this moment? Enroll to get our biotech publication in ...
Folks have been using the GLP-1 wave to realize fast and vital weight reduction. However given the drug’s impact on ...
When the top of the nation's largest publicly operated well being plan worries concerning the looming federal cuts to Medicaid, ...
Adam Feuerstein is a senior writer and biotech columnist, reporting on the crossroads of drug development, business, Wall Street, and ...
Health systems have to take responsibility for the broken prior authorization process and stop deferring action to payers, according to ...
Former Cano Health CEO Marlow Hernandez is facing a jury trial this week over allegations of fraud and corruption. The ...
When Dr. Rahul Bansal left India to continue his research at one of the universities in Pittsburgh, he carried with ...
The hype around AI in healthcare is undeniable. AI startups are dominating the digital health investment market, companies like Abridge ...
For the third time this year, a patient treated with a Sarepta Therapeutics gene therapy has died, a revelation that ...
Our Season 2 – Innovations in Oncology – continues with a focus on precision medicine. I talk with CEO of ...
Copyright © 2025 Your Health 24 7.
Your Health 24 7 is not responsible for the content of external sites.
Copyright © 2025 Your Health 24 7.
Your Health 24 7 is not responsible for the content of external sites.